Relationship between Microsatellite Alterations of RASSF1A Gene and Development of Cervical Carcinoma

Objective: To explore the relationship between microsatellite alterations of RASSFIA gene and the development of cervical carcinoma, and its relationship with HPV16 infection. Methods: Two sites of microsatellite polymorphism of RASSFIA gene were selected. Polymerase chain reaction (PCR) technique w...

Full description

Saved in:
Bibliographic Details
Published inChinese journal of cancer research Vol. 19; no. 1; pp. 45 - 51
Main Author 赵富玺 燕杰 刘润花 王喜英 崔克
Format Journal Article
LanguageEnglish
Published Institute of Microorganism and Immunology, Datong 037008%Institute of Surgery, Medical College of Datong University, Datong 037008 01.03.2007
Subjects
Online AccessGet full text
ISSN1000-9604
1993-0631
DOI10.1007/s11670-007-0045-1

Cover

More Information
Summary:Objective: To explore the relationship between microsatellite alterations of RASSFIA gene and the development of cervical carcinoma, and its relationship with HPV16 infection. Methods: Two sites of microsatellite polymorphism of RASSFIA gene were selected. Polymerase chain reaction (PCR) technique was used to detect LOH and MSI in 50 cases of cervical carcinoma and 40 cases of cervical intraepithelial neoplasia (CIN), and to detect the infection state of HPV16. Results: At D3S1478 and D3S4604, the LOH rates of cervical carcinomas were 32.6% (14/43) and 48.9% (23/47), the MSI rates were 14% (6/43) and 19.1% (9/47), respectively. The LOH rates of CINs were 31.4% (11/35) and 39.5% (15/38), the MSI rates were 11.4% (4/35) and 15.8% (6/38), respectively. There were no significant differences between cervical carcinomas and CINs in respect to their positive rates of LOH and MSI at D3S1478 and D3S4604 (P〉0.05). There were significant differences in LOH rates at D3S1478 and D3S4604 between the stage Ⅰ-Ⅱ and Ⅲ-Ⅳ cervical carcinomas and between the well/moderately differentiated cervical carcinomas and the poorly differentiated cervical carcinomas (P〈0.05). The positive rates of LOH and MSI for CIN Ⅲ and noninvasive cervical carcinomas were higher than those in CIN Ⅰ-Ⅱ. The rates of infection of HPV16 in cervical cancer was obviously higher than that in CIN and in normal cervical tissues (P〈0.05), and the incidence of LOH of RASSFIA gene was higher in HPV16(+) than that in HPV16(-) (P〈0.05). Conclusion: The RASSFIA gene change is a relatively late event in cervical carcinomas. The detection of LOH and MSI of RASSFIA gene might be helpful to the early diagnosis and the screening of cervical carcinoma. It might also be useful for predicting the prognosis of cervical carcinoma.
Bibliography:Human papillomavirus
R737.33
RASSF1A gene
Loss of heterozygosity
11-2591/R
RASSF1A gene; Loss of heterozygosity; Microsatellite instability; Cervical carcinoma; Human papillomavirus
Microsatellite instability
Cervical carcinoma
ISSN:1000-9604
1993-0631
DOI:10.1007/s11670-007-0045-1